| Zugriffsnummer |
Gehäuse Q9XSX5 |
| Assay-Bereich |
24.58 bis 6000 pg/ml |
| Assay-Empfindlichkeit: |
25 pg/mL |
| Kalibrierbereich |
25 bis 6000 pg/ml |
| Inhalt und Lagerung |
Pre-coated 96-well plate, standard, detector antibody, streptavidin-HRP, diluents, wash buffer, chromogen, stop solution, and plate covers. May be stored at 2–8°C for up to 6 months from the date of shipment. |
| Assay |
Festphasen-Sandwich-ELISA |
| Konjugat |
Biotin |
| Immunassay-Kit-Format |
Sandwich ELISA Kit |
| Produkttyp |
ELISA-Kit |
| Proteinfamilie |
GCPR |
| Probentyp |
Plasma, Serum, Überstand |
| Spezifität |
Dieses ELISA-Antikörperpaar erkennt Katzen-IL-8. Andere Arten wurden nicht bestimmt |
| Ausreichend für |
96 Assays |
| Zielspezies |
Katzen- |
| Zur Verwendung mit (Anwendung) |
ELISA, Protein-Assays, Proteinbiologie, Krebsbiologie, Immunologie, Neurowissenschaften, Neurobiologie, Proteinnachweis, Proteinanalyse |
| Zur Verwendung mit (Geräte) |
Kolorimetrisches Mikrotiterplatten-Lesegerät |
| Gen-Alias |
(Ala-IL-8)77; (Ser-IL-8)72; Alveolar macrophage chemotactic factor I; alveolar macrophage-derived chemotactic factor-I; AMCF-I; ANX7; beta endothelial cell-derived neutrophil activating peptide; beta-thromboglobulin-like protein; chemokine (C-X-C motif) ligand 8; C-X-C motif chemokine 8; C-X-C motif chemokine ligand 8; CXCL8; cytokine 8; emoctakin; GCP/IL-8 protein I; GCP/IL-8 protein II; GCP/IL-8 protein III; GCP/IL-8 protein IV; GCP/IL-8 protein V; GCP/IL-8 protein VI; GCP1; GCP-1; Granulocyte chemotactic protein 1; IL8; IL-8; IL-8(1-77); IL-8(5-77); IL-8(6-77); IL-8(7-77); IL-8(8-77); IL-8(9-77); IL8/NAP1 form I; IL8/NAP1 form II; IL8/NAP1 form III; IL8/NAP1 form IV; IL8/NAP1 form V; IL8/NAP1 form VI; ILN; Interleukin; interleukin 8; Interleukin8; interleukin-8; interleuklin-8 precursor; LECT; LUCT; lung giant cell carcinoma-derived chemotactic protein; lymphocyte derived neutrophil activating peptide; Lymphocyte-derived neutrophil-activating factor; LYNAP; MDNCF; MDNCF-a; MDNCF-b; MDNCF-c; MONAP; Monocyte-derived neutrophil chemotactic factor; monocyte-derived neutrophil-activating peptide; NAF; NAP1; NAP-1; neutrophil activating peptide 1; neutrophil and T-lymphocyte chemotactic and activating factor; Neutrophil attractant/activation protein 1; neutrophil attractant/activation protein-1; Neutrophil-activating factor; neutrophil-activating peptide 1; Neutrophil-activating protein 1; Permeability factor 1; PF1; Protein 3-10C; RP11-537A6.8; RPF1; small inducible cytokine subfamily B, member 8; SNX; SYNEXIN; T-cell chemotactic factor; tumor necrosis factor-induced gene 1(Ala-IL-8)77; (Ser-IL-8)72; Alveolar macrophage chemotactic factor I; alveolar macrophage-derived chemotactic factor-I; AMCF-I; ANX7; beta endothelial cell-derived neutrophil activating peptide; beta-thromboglobulin-like protein; chemokine (C-X-C motif) ligand 8; C-X-C motif chemokine 8; C-X-C motif chemokine ligand 8; CXCL8; cytokine 8; emoctakin; GCP/IL-8 protein I; GCP/IL-8 protein II; GCP/IL-8 protein III; GCP/IL-8 protein IV; GCP/IL-8 protein V; GCP/IL-8 protein VI; GCP1; GCP-1; Granulocyte chemotactic protein 1; IL8; IL-8; IL-8(1-77); IL-8(5-77); IL-8(6-77); IL-8(7-77); IL-8(8-77); IL-8(9-77); IL8/NAP1 form I; IL8/NAP1 form II; IL8/NAP1 form III; IL8/NAP1 form IV; IL8/NAP1 form V; IL8/NAP1 form VI; ILN; Interleukin; interleukin 8; Interleukin8; interleukin-8; interleuklin-8 precursor; LECT; LUCT; lung giant cell carcinoma-derived chemotactic protein; lymphocyte derived neutrophil activating peptide; Lymphocyte-derived neutrophil-activating factor; LYNAP; MDNCF; MDNCF-a; MDNCF-b; MDNCF-c; MONAP; Monocyte-derived neutrophil chemotactic factor; monocyte-derived neutrophil-activating peptide; NAF; NAP1; NAP-1; neutrophil activating peptide 1; neutrophil and T-lymphocyte chemotactic and activating factor; Neutrophil attractant/activation protein 1; neutrophil attractant/activation protein-1; Neutrophil-activating factor; neutrophil-activating peptide 1; Neutrophil-activating protein 1; Permeability factor 1; PF1; Protein 3-10C; RP11-537A6.8; RPF1; small inducible cytokine subfamily B, member 8; SNX; SYNEXIN; T-cell chemotactic factor; tumor necrosis factor-induced gene 1; IL8 |
| Gen-ID (Entrez) |
493836 |
| Gensymbol |
CXCL8 |
| Interassay-VK |
< 12 % |
| Intraassay-VK |
< 10 % |
| Kitinhalt |
Vorbeschichtete 96-Well-Platte, Standard, Biotinylierter Nachweisantikörper, Biotinylierter Nachweisantikörper, SAV-HRP, Waschpuffer, Chromogen, Stopplösung, Dichtungsfolien für Mikrotiterplatten |
| Marker oder Farbstoff |
HRP |
| Protein-Aliase |
IL-8, C-X-C motif chemokine 8, Chemokine (C-X-C motif) ligand 8 |
| Menge |
96 Tests |
| Kennzeichnung |
RUO |
| Forschungsgebiet |
Extrazelluläre Matrix und Zelladhäsion |
| Probenvolumen |
Plasma, 50 μl; Serum, 50 μl; Überstand, 100 μl |
| Versandbedingung |
Wet or Dry Ice |
| Lagerungsbedingungen |
2 bis 8 °C |
| Synonym |
IL8 |
| Ziel |
Katzen- |
| Prüfzeit |
1 h 20 min |
| Gesamte Assay-Zeit |
4 h 45 min |
|
Mehr anzeigen
Weniger anzeigen
|
|